2009 Midyear Clinical Meeting
Click here to go to the previous page
Managing Anticoagulation Therapy: An Advanced Workshop for Pharmacists 2009
Track:
Pre-Meeting Workshops (CE)
Program Code: 298-L01
Date: Sunday, December 6, 2009
Time: 8:30 AM to 4:30 PM EST
Location:
Veronese 2405
MEETING PLANNING ASSOCIATE:
Dr. William Dager, PharmD, FCSHP, Pharmacist Specialist, UC Davis Medical Center
PRESENTER(S):
Dr. William Dager, PharmD, FCSHP, Pharmacist Specialist, UC Davis Medical Center
John Fanikos,
RPh, MBA, Assistant Director of Pharmacy,
Brigham and Women's
John Fanikos, R.Ph., M.B.A. is currently the Assistant Director of Pharmacy at Brigham and Womens Hospital (BWH), Boston, Massachusetts. He also an Assistant Professor of Clinical Pharmacy Practice at both Northeastern University and Massachusetts College of Pharmacy. He received his B.S. in Pharmacy from the Massachusetts College of Pharmacy in 1984. He completed an ASHP accredited residency program at Brigham and Womens Hospital in 1985. He received his M.B.A from Northeastern University in 1994. He has served in a number of different roles at Brigham and Womens ranging from investigational drug pharmacist to inpatient and outpatient pharmacy supervisor, to clinical preceptor to pharmacy administrator. Through his pharmacy practice he has worked with orthopedic, oncology, cardiology and general medicine patients. He has spent the past three years working with the BWH Anticoagulation Service and expanding the role of the Pharmacist. He is from a family of pharmacists (father, brother) and is well aware of many of the issues facing the Medical profession in a wide range of practice settings.
|
Michael Gulseth,
PharmD, BCPS, Program Director for Anticoagulation Services,
Sanford USD Medical Center, Department of Pharmaceutical Services
Michael P. Gulseth, Pharm.D., BCPS is Program Director for Anticoagulation Services at the Sanford University of South Dakota Medical Center, Department of Pharmaceutical Services in Sioux Falls, South Dakota. Dr. Gulseth received his Doctor of Pharmacy degree in 1999 from North Dakota State University in Fargo, North Dakota. He completed residency training at United Hospital in St. Paul, Minnesota. He is lead author and editor of Managing Anticoagulation Patients in the Hospital: the Inpatient Anticoagulation Service, published in 2007 by the American Society of Health-System Pharmacists.
Dr. Gulseth is a member of the Editorial Advisory Board of the American Journal of Health-System Pharmacy. Dr. Gulseth is an active member of several professional pharmacy organizations, including the American Society of Health-System Pharmacists, the Minnesota and South Dakota Societies of Health-System Pharmacists, and the American College of Clinical Pharmacy. His research interests include evaluation of antithrombotic therapies in the inpatient setting and evaluation of the benefits of pharmacist-managed inpatient anticoagulation services.
|
Edith Nutescu,
PharmD, FCCP, Clinical Professor and Director, Antithrombosis Center,
University of Illinois at Chicago
Edith A. Nutescu, Pharm.D., FCCP, is Clinical Professor of Pharmacy Practice and Director of the Antithrombosis Center at the University of Illinois at Chicago College of Pharmacy and Medical Center. Dr. Nutescu is also part of the Faculty at the University of Illinois at Chicago, Center for Pharmacoeconomic Research. She earned her Pharm.D. degree with high honors at the University of Illinois at Chicago College of Pharmacy. After graduation, Dr Nutescu went on to complete an American Society of Health-System Pharmacists (ASHP) accredited Pharmacy Practice Residency at Lutheran General Hospital Advocate Health Care and a Primary Care Specialty Residency at the University of Illinois at Chicago Medical Center.
As a clinician and educator, Dr. Nutescu has contributed extensively to the care of patients and the education of students and health care providers on topics related to cardiovascular therapeutics and thrombosis. Dr. Nutescu maintains an active clinical practice and research program. Her research and practice interests are in the areas of thrombosis, antithrombotic therapy, cardiovascular diseases, and stroke. Dr Nutescu has authored or co-authored over 100 scientific articles, book chapters, and abstracts published in the science and medical literature and has served as a reviewer for the literature in her field. She serves on the Editorial Boards for Annals of Pharmacotherapy and the American Journal of Health-System Pharmacy and serves as the Vice-President and on the Board of Directors for the Anticoagulation Forum.
|
Maureen Smythe,
PharmD, Coordinator of Student and Resident Education, Department of Pharmacy Services,
William Beaumont Hospital
Maureen A. Smythe, PharmD, FCCP, is a Professor of Pharmacy Practice at the Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University in Detroit, Michigan. She holds a cross appointment with the Department of Pharmaceutical Services at William Beaumont Hospital in Royal Oak, Michigan.
Dr. Smythe has established a practice based research program in the area of inpatient anticoagulation
|
Ann Wittkowsky,
PharmD, CACP, Director, Anticoagulation Services,
University of Washington Medical Center
Ann K. Wittkowsky, PharmD, CACP, FASHP, FCCP is Clinical Professor of Pharmacy at the University of Washington School of Pharmacy and Director of Anticoagulation Services at the University of Washington Medical Center. As a clinician and educator in the field of antithrombotic pharmacotherapy, she has contributed extensively to the care of patients and the education of health care providers regarding antithrombotic pharmacotherapy.
She is the author of over 100 scientific papers, book chapters and abstracts, and co-editor of the textbook Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines. She has lectured widely throughout the United States and Canada, maintains an active clinical research program, and is board certified as an anticoagulation care provider. Dr. Wittkowsky serves as an editorial board member for Pharmacotherapy and the Journal of Thrombosis and Thrombolysis, as a reviewer for numerous medical and scientific journals, and as a member of the board of directors of The Anticoagulation Forum, a multidisciplinary organization of anticoagulation care providers. She is the director of the Northwest Anticoagulation Consortium, a preceptor for the ASHP Research and Education Foundations Antithrombotic Pharmacotherapy Traineeship, a member of the Board of Regents of the American College of Clinical Pharmacy, and of the Board of Directors of Pharmacotherapy. Dr Wittkowsky was a member of the American College of Chest Physicians 8th Conference on Antithrombotic and Thrombolytic Therapy and was recently selected to serve as an author for the 9th edition of these guidelines.
|
Description
ACPE Activity #204-000-09-298-L01
7.0 Contact Hours / Application-based
Pre-registration required; onsite registration not available.
Faculty: William E. Dager, PharmD, FCSHP, Pharmacist Specialist, UC Davis Medical Center, Sacramento, CA; John Fanikos, RPh, MBA, Assistant Director of Pharmacy, Brigham and Women's Hospital, Boston, MA; Michael P. Gulseth, PharmD, BCPS, Program Director for Anticoagulation Services, Sanford USD Medical Center, Department of Pharmaceutical Services, Sioux Falls, SD; Edith A. Nutescu, PharmD, FCCP, Clinical Professor and Director, Antithrombosis Center, University of Illinois at Chicago, Chicago; Maureen A. Smythe, PharmD, FCCP, Coordinator of Student and Resident Education, Department of Pharmacy Services, William Beaumont Hospital, Detroit and Royal Oak, MI; and Ann K. Wittkowsky, PharmD, CACP, FASHP, Director, Anticoagulation Services, University of Washington Medical Center, Seattle
Learning Objectives:
LEARNER OUTCOMES:
- Describe approaches to documenting and supporting continued activities related to managing anticoagulation therapy.
- Describe approaches to switching between, overlapping, holding, or reversing anticoagulants.
- Develop and communicate an anticoagulant management plan.
- Discuss approaches to establishing and revising protocols for anticoagulation therapy.
- Identify situations potentially predisposing patients to adverse anticoagulation related events and discuss approaches to initiating and monitoring anticoagulant therapy.